Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: The role of Ureaplasma urealyticum

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4843-4849

  Lukic, A ^a   Canzio, C ^a   Patella, A ^a   Giovagnoli, M R ^a   Cipriani, P ^a   Frega, A ^a   Moscarini, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cervical cytology; Cervicovaginal infections; Co factors; HPV infection; Ureaplasma urealyticum

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BACTERIUM EXAMINATION; CHLAMYDIA TRACHOMATIS; COLPOSCOPY; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROORGANISM DETECTION; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MIDDLE AGED; PRECANCEROUS CONDITIONS; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS; VAGINAL DISEASES; VAGINAL NEOPLASMS;

EID: 33845933214     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bornstein J, Rahat MA and Abramovici H: Etiology of cervical cancer: current concepts. Obstet Gynecol Surv 60: 146-154, 1995.
2. Castellsaguè X, Bosch FX and Munoz N: Environmental cofactors in HPV carcinogenesis. Vir Res 89: 191-199, 2002.
3. Castel PE, Giuliano AR: Genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as human papillomavirus cofactors. J Natl Cancer Inst Monographs N. 31, cap. 4, 2003.
4. Vecchione A, Cermele C and Giovagnoli MR: p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 55: 343-348, 1994.
5. Koffa M, Koumantakis E and Ergazaki M: Association of herpes virus infection with the development of genital cancer. Int J Cancer 63: 58-62, 1995.
6. Pisani S, Gallinelli C, Seganti A et al: Detection of viral and bacterial infections in women with normal and abnormal colposcopy. Eur J Gynecol Oncol 20: 69-73, 1999.
7. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J et al: Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. J Natl Cancer Inst 94: 1604-1613, 2002.
8. Boyle DCM and Smith JR: Infection and cervical intraepithelial neoplasia. Int J Gynecol Cancer 9: 177-186, 1999.
9. Zhang Z and Begg C: Is Trichomonas vaginalis a cause of cervical intraepithelial neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol 23: 682-690, 1994.
10. Smith JS, Munoz N, Herrero R et al: Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324-331, 2002.
11. Tamin H, Finan RR, Sharida HE, Rashid M and Almawi WY: Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microb Infect Dis 43: 277-281, 2002.
12. Fisher N: Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynecol Oncol 3: 247-250, 2002.
13. Edelman M, Fox A, Alderman E et al: Cervical papanicolau smear abnormalities and Chlamydia trachomatis in sexually active adolescent females. J Pediatr Adolesc Gynecol 13: 65-69, 2000.
14. Platz-Christensen J, Sundstrom E and Larsson P: Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 73: 586-588, 1994.
15. Eltabbakh GH, Eltabbakh GD, Broekhuizen FF et al: Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women. Obstet Gynecol 85: 499-503, 1995.
16. Peters N, Van Leeuwen AM, Pieters WJLM et al: Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey on women with dyscaryotic smears. Sex Transm Dis 22: 296-302, 1995.
17. Nindl I, Lorincz A, Mielzynska I et al: Human papillomavirus detection in cervical intra-epithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 10: 49-56, 1998.
18. Guijon F, Paraskevas M, Rand F et al: Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int J Gynecol Obstet 37: 185-191, 1992.
19. Solomon D, Davey D, Kurman R et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114-2119, 2002.
20. Stafl A and Wilbanks GD: An international terminology of colposcopy: Report of the Nomenclature Committee of the International Federation of Cervical Pathology and Colposcopy. Obstet Gynecol 77: 313-314, 1991.
21. Castle PE, Hillier SL, Rabe LK, Hidesheim A, Herrero R, Bratti MC, Sherman ME et al: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epid Biom Prev 10: 1021-1027, 2001.
22. Sweet RL: Gynecologic conditions and bacterial vaginosis: implications for the non-pregnant patient. Inf Dis Obstet Gynecol 8: 184-190, 2000.
23. Eckert LO, Koutsky LA, Kiviat NB, Kronf MR, Stevens CE and Eschenbach DA: The inflammatory papanicolau smear: what does it mean? Obstet Gynecol 86: 360-366, 1995.
24. Nobbenhuis M, Walboomers JM, Heimerhorst TI and Rozendaal L: Relationship of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 354: 20-25, 1999.
25. Ho GYF, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. NEJM 338: 423-428, 1998.
26. Van den Brule AJC, Walboomers JMM, Maine MD et al: Difference in the prevalence of human papillomavirus in cytomorphologically normal cervix smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48: 404-408, 1991.
27. Peyton CL, Gravitt PE, Hunt WC et al: Determinants of genital human papillomavirus detection in a US population. J Infect Dis 183: 1554-1564, 2001.
28. Clavel C, Masure M, Bory JP et al: Human papillomavirus testing in primary screening for the detection of high grade cervical lesions: a study of 7932 women. Brit J Cancer 89: 1616-1623, 2001.
29. Cox JT, Lorincz AT, Schiffman MH et al: HPV testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of ASCUS. Am J Obstet Gynecol 172: 946-954, 1995.
30. Manos MM, Kinney WK, Hurley LB et al: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281: 1605-1610, 1999.
31. Solomon D, Schiffman MH and Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undeterminated significance: baseline reuslts from a randomized trial. J Natl Cancer Inst 93: 293-299, 2001.
32. The Atypical Squamous cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions:baseline data from a randomized tiral. J Natl Cancer Inst 92:1014-1018, 2000.
33. Paavonen J and Lehtinen M: Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer. Curr Opin Infect Dis 12: 67-71, 1999.
34. Schlott T, Eiffert H, Bohne W et al: Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Gynecol Oncol 98: 409-419, 2005.
35. Pudney J, Quayle AJ and Anderson DJ: Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73: 253-263, 2005.